Rheumatoid Arthritis

In Rheumatoid Arthritis (RA), the most common chronic inflammatory joint disease, autoantibodies attack the joints and cause joint destruction. Below are COVID news and research updates that specifically relate to RA.

Weighing the Pros and Cons of Pausing Methotrexate for COVID shots

A recently published study in the Annals of the Rheumatic Diseases analyzed the pros and cons of pausing methotrexate usage. The group that continued their regular medication regimen demonstrated a 55% antibody response from the COVID vaccines whereas the group that paused methotrexate demonstrated an 80% antibody response.

Read More »

Covid-19 Outcomes in Autoimmune Disease Patients

Autoimmune disease is currently considered a risk factor for severe COVID-19. A research article published in Rheumatology last Fall summarized 30-day outcomes of autoimmune disease (AD) patients following hospitalization with COVID-19. AD patients diagnosed and/or hospitalized between January and June 2020 with COVID-19 were included, and their 30 day outcomes were compared to patients with at least one AD hospitalized with influenza from September 2017 through April 2018.

Read More »
Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.